Cath Lab Digest
Radial access has been shown to improve outcome by not only lowering the risk of bleeding during coronary intervention, but also by improving mortality in STEMI patients. Dealing with tortuous arteries requires a level of experience that can be obtained by using radial access in older female patients during elective cases and building a protocol […]
Malignant or interarterial course of the large epicardial coronary arteries can cause myocardial ischemia, angina, acute coronary syndromes, congestive heart failure, or sudden cardiac death. This is a case of an 18-year-old healthy collegiate basketball player who presented with ventricular fibrillation and cardiogenic shock due to an interarterial and intramural course of an anomalous left […]
Cutting Edge Technology Feature: Interview with Rajiv Jauhar, MD, FACC, FSCAI, Chief of Cardiology, Northwell Health, Manhasset, New York.
As endovascular treatment options have improved over the years, it is now possible to treat lesions with a minimally invasive approach that would have previously required a surgical intervention.
How is artificial intelligence (AI) interacting with computed tomography angiography (CTA) to help interventionalists in their decision making?
Atheroablative technologies are available but have significant limitations, and now we have a novel technology: intravascular lithotripsy.
Case Report: percutaneous coronary intervention (PCI) of a right coronary artery (RCA) with zero radio-contrast use, and PCI of the distal left main coronary artery (LM) into the left anterior descending artery (LAD) using minimal radio-contrast use, facilitated by the SyncVision Precision Guidance System (Philips).
CLD talks with Tony DeMartini, MD, Associate Professor, Department of Internal Medicine, SIU Heart & Vascular Center, Memorial Medical Center, Springfield, Illinois.
FUTURE BTK is a randomized, double blind, placebo-controlled, multi-center trial. It is aimed at determining the effectiveness of MagicTouch PTA sirolimus coated balloon versus standard balloon angioplasty for the treatment of below the knee arterial disease in critical limb ischemia (CLI) patients.
(New York, NY – August 19, 2020)- Mount Sinai Heart is the first site on the East Coast offering a new device for stroke prevention in patients with a dangerous type of atrial fibrillation. The implant, called “WATCHMAN FLX,” was approved in July by the U.S. Food and Drug Administration. It represents a new generation of its […]
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!